Protective Role of rAAV-NDI1, Serotype 5, in an Acute MPTP Mouse Parkinson's Model
Figure 1
Comparison of NDI1 expression levels in the SN when using AAV serotype 5 versus serotype 2. All images were obtained approximately 2 months after injection of AAV-NDI1 in control mice. (a) NDI1 expression after injection of rAAV5-NDI1, (b) TH levels in SN corresponding to (a). (c) NDI1 expression after injection of AAV-NDI1 serotype 2, (d) TH levels in SN corresponding to (c). Scale bar = 200 μm for (a) and (b), and 200 μm for (c) and (d).